Study setting and participants
death
SECONDARY
This is a pre-planned secondary analysis of a multicentre, double-blind, randomised, placebo-controlled trial, which investigated adjunct prednisone for patients with CAP on the primary outcome of time to death from any cause. The study protocol of the initial STEP-trial has been published elsewhere [